Dabigatran vs rivaroxaban for cerebral venous thrombosis
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a new blood clot in a brain vein confirmed by a scan (CT or MRI)
- You can start the study medicine within 14 days of that scan
- You are able to swallow pills
- You do not have severe kidney problems, a bleeding disorder, or a condition that requires other blood thinners
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two blood thinners (dabigatran and apixaban) to see which works better for treating a blood clot in the brain's veins. It might help you if you have a new diagnosis of this type of clot and can take oral blood thinners.
This trial tests a minimally invasive procedure to remove blood clots from veins in the brain (cerebral venous sinus thrombosis). If you've had symptoms like severe headache, seizures, or weakness within the past 3 weeks and imaging confirms a clot, this study may help restore blood flow and prevent serious complications.
This trial compares two blood thinners, Rivaroxaban and Apixaban, to see which works better for people with a blood clot in a brain vein. It may help find the safest and most effective treatment for this condition.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
This trial tests a type of blood thinner called DOACs for people with a clot in a brain vein (cerebral venous thrombosis). DOACs may be an easier treatment option, and this study looks at how well they work in adults in Vietnam.
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Hear when a new Cerebral Venous Sinus Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.